Safety and efficacy of cetuximab-containing chemotherapy after immune checkpoint inhibitors for patients with squamous cell carcinoma of the head and neck: a single-center retrospective study

Immunotherapy has been shown to prolong survival in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) in front-line use; however, subsequent systemic therapy has not been optimized. This study aimed to evaluate the safety and efficacy of cetuximab-containing chemotherapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurosaki, Takashi, Mitani, Seiichiro, Tanaka, Kaoru, Suzuki, Shinichiro, Kanemura, Hiroaki, Haratani, Koji, Fumita, Soichi, Iwasa, Tsutomu, Hayashi, Hidetoshi, Yoshida, Takeshi, Ishikawa, Kazuki, Kitano, Mutsukazu, Otsuki, Naoki, Nishimura, Yasumasa, Doi, Katsumi, Nakagawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748051/
https://www.ncbi.nlm.nih.gov/pubmed/32976215
http://dx.doi.org/10.1097/CAD.0000000000001006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748051/
https://www.ncbi.nlm.nih.gov/pubmed/32976215
http://dx.doi.org/10.1097/CAD.0000000000001006

Ejemplares similares